Aim
To develop a range of standardised paediatric PN formulations for use in children from 5kg – 44kg body weight, (6months – 18yrs) accompanied by comprehensive, clinical, prescribing and administration guidelines based on and referenced to the latest published evidence.
It is envisaged that this provision will help to facilitate a change in practice towards a greater use of standardised PN, and in doing so, provide a platform for better equity of care and improved safety of PN for infants and children by reducing the risk of errors in the prescription, compounding, delivery and monitoring of PN.
